Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05611580 · ClinicalTrials.gov registry record · NA

Rural Chronic Disease Risk Reduction

A NA study of Chronic Disease and Risk Reduction, sponsored by Florida State University.

Completed
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT05611580: Completed NA study of Chronic Disease and Risk Reduction, sponsored by Florida State University.

NCT05611580 is a NA study of Chronic Disease and Risk Reduction that has completed, run by Florida State University. The registered enrollment target is 80 participants, below the 89,942-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05611580, a NA study of Chronic Disease and Risk Reduction, has completed, sponsored by Florida State University.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

This study tests a web-based chronic disease risk reduction lifestyle medicine intervention among rural adults.

Primary Outcome

Theory of Planned Behavior 5-a-day Questionnaire: The 12-item scale for measuring produce consumption had adequate internal reliability for attitudes (Cronbach"s a = .79), norms (a = .77), self-efficacy (a = .81), and intentions (a = .74) when tested among a diverse population. The range of possible scores for each of the subscales for this instrument varied for attitudes (3 to 28), norms and self-efficacy (3 to 21), and intentions (1 to 14). Higher scores indicate greater compliance with dieta

Interventions

  • BEHAVIORAL Chronic Disease Risk Reduction

Study Locations (1)

Florida

  • Florida State University College of Nursing - Tallahassee

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2023-01-01
Est. Completion 2024-05-31
Phase NA
Florida State University

219 total trials

What the finished NCT05611580 record still lists

NCT05611580 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 89,942-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower).

The record links to 2 conditions, with Chronic Disease appearing as the primary indexed condition, and to 1 intervention - of which Chronic Disease Risk Reduction is the first listed.

NCT05611580 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT05611580 about?

NCT05611580 is a clinical study titled "Rural Chronic Disease Risk Reduction". This study tests a web-based chronic disease risk reduction lifestyle medicine intervention among rural adults.

What is the current status of trial NCT05611580?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2023-01-01. Estimated completion is 2024-05-31.

What conditions does trial NCT05611580 study?

This clinical trial studies the following conditions: Chronic Disease, Risk Reduction.

What interventions are being tested in trial NCT05611580?

The interventions under investigation include: Chronic Disease Risk Reduction (BEHAVIORAL).

Who is sponsoring clinical trial NCT05611580?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05611580 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05611580's enrollment target sits among peer trials

80 35th of 48 higher than 13 of 48 other Chronic Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05611580, the US trial registry maintained by the National Library of Medicine. NCT05611580 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.